Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (638)	8/28/2001 12:32:45 PM
From: tuck	Read Replies (1) \| Respond to of 2243

Rick, SI software getting strange. My spelling checker doesn't work, but I just modified both original messages a couple of days ago (for similar reasons) without any trouble. We all got our crosses to bear. Plenty of pickings around, in BLUE H and elsewhere. VLTS near lows, for example, off of radar since Mike finally bailed. In BLUE, I'm currently tempted by AGIX (we can pay a tad less than Peter! Always an accomplishment in my book), ARNA, LEON, & yes, MCLS. I suspect the former would look the most interesting to you for T/FIF. LSBC & VGNX go without saying at this point, and we probably own enough. Still wondering what the DDDP insiders had on their minds when they bought, considering Miljenko's take on the uncertainties there. Would they have been analyzing data at the time of the buys, perhaps? Good data? Talking about another deal with somebody? Thinking of adding. A basket of depressed biotechs that have made noises about landing deals. Another angle? Cheers, Tuck